Clinical Trial Update: Study of Uveitic Macular Edema Treated With Ranibizumab or Steroids [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating ranibizumab or steroids for uveitic macular edema has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Macular Edema
• Uveitis

Drugs mentioned

• Corticosteroids (corticosteroids)
• Ranibizumab (ranibizumab)

Snippet

Sponsor: University of Utah | Conditions: Macular Edema, Uveitis | Phase 2 | Status: WITHDRAWN